Role of calcium ionophore A23187-induced activation of IkappaB kinase 2 in mast cells

International Archives of Allergy and Immunology

Volumn 161, Issue , 2013, Pages 37-43

  Hosokawa, Junichi ^a   Suzuki, Kotaro ^a   Nakagomi, Daiki ^a   Tamachi, Tomohiro ^a   Takatori, Hiroaki ^a   Suto, Akira ^a   Nakajima, Hiroshi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Calcium; IkappaB kinase 2; Mast Cell

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; ARACHIDONIC ACID; CALCIMYCIN; CALCIUM ION; I KAPPA B ALPHA; I KAPPA B KINASE; I KAPPA B KINASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE C BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; CALCIUM IONOPHORE; CHUK PROTEIN, HUMAN; CYTOKINE; IKK2 PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C;

ANIMAL CELL; BONE MARROW DERIVED MAST CELL; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FETUS; FETUS LIVER; GENE INDUCTION; HISTAMINE RELEASE; IMMUNOBLOTTING; INTRACELLULAR SIGNALING; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; ARTICLE; BIOSYNTHESIS; CALCIUM SIGNALING; CELL CULTURE; DEGRANULATION; DRUG EFFECT; HUMAN; IMMUNOLOGY; MAST CELL; METABOLISM; PHOSPHORYLATION;

CALCIMYCIN; CALCIUM IONOPHORES; CALCIUM SIGNALING; CELL DEGRANULATION; CELLS, CULTURED; CYTOKINES; ENZYME ACTIVATION; HUMANS; I-KAPPA B KINASE; MAST CELLS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTEIN KINASE C; RECEPTORS, INTERLEUKIN-1; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I;

MLCS; MLOWN;

EID: 84880562126     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000350357     Document Type: Conference Paper

References (30)

1. Galli SJ, Nakase S, Tsai M: Mast cells in the development of adaptive immune responses. Nat Immunol 2005; 6:135-142.
2. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M: Mast cells as 'tunable' effector and immunoregula-tory cells: recent advances. Annu Rev Immunol 2005; 23:749-786.
3. 2+ mobilization and its regulation in mast cell functions. Front Immunol 2012; 3:1-10.
4. Ma H-T, Beaven MA: Regulation of Ca2+ signaling with particular focus on mast cells. Crit Rev Immunol 2009; 29:155-186.
5. Feske S: Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol 2007; 7:690-702.
6. Oh-hora M, Rao A: Calcium signaling in lymphocytes. Curr Opin Immunol 2008; 20:250-258.
7. Oh-hora M: Calcium signaling in the development and function of T-lineage cells. Immunol Rev 2009; 231:210-231.
8. 2+ response amplitude and duration. Nature 1997; 386:855-858.
9. Dolmetsch RE, Xu K, Lewis RS: Calcium oscillations increase the efficiency and specificity of gene expression. Nature 1998; 392:933-936.
10. Hayden MS, Ghosh S: Signaling to NF-κB. Genes Dev 2004; 18:2195-2224.
11. Li Q, Verma IM: NF-κB regulation in the immune system. Nat Rev Immunol 2002; 2:725-734.
12. Scheidereit C: IκB kinase complexes: gateways to NF-κB activation and transcription. Oncogene 2006; 25:6685-6705.
13. Perkins ND: Integrating cell-signaling pathways with NF-κB and IKK function. Nat Rev Mol Cell Biol 2007; 8:49-62.
14. Suzuki K, Verma IM: Phosphorylation of SNAP-23 by IkappaB kinase 2 regulates mast cell degranulation. Cell 2008; 134:485-495.
15. Klemm S, Gutermuth J, Hultner L, Sparwas-ser T, Behrendt H, Peschel C, Mak TW, Jakob T, Ruland J: The Bcl10-Malt1 complex segregates Fc epsilon RI-mediated nuclear factor kappa B activation and cytokine production from mast cell degranulation. J Exp Med 2006; 203:337-347.
16. Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM: Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 1999; 284:321-325.
17. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D: Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 1995; 376:167-170.
18. Glaccum MB, Stocking KL, Charrier K, Smith JL, Willis CR, Maliszewski C, Livingston DJ, Peschon JJ, Morrissey PJ: Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J Immunol 1997; 159:3364-3371.
19. Peschon JJ, Torrance DS, Stocking KL, Glac-cum MB, Otten C, Willis CR, Charrier K, Morrissey PJ, Ware CB, Mohler KM: TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol 2004; 160:943-952.
20. Suzuki K, Nakajima H, Kagami S-I, Suto A, Ikeda K, Hirose K, Hiwasa T, Takeda K, Saito Y, Akira S, Iwamoto I: Proteolytic processing of Stat6 signaling in mast cells as a negative regulatory mechanism. J Exp Med 2002; 196: 27-38.
21. Klemm S, Ruland J: Inflammatory signal transduction from the FcεRI to NF-κB. Im-munobiology 2006; 211:815-820.
22. Abramson J, Pecht I: Regulation of the mast cell response to the type I Fcε receptor. Immunol Rev 2007; 217:231-254.
23. Basu A, Sivaprasad U: Protein kinase Cε makes the life and death decision. Cell Signal 2007; 19:1633-1642.
24. 2+, and calmodulin. Cell Signal 2002; 14:649-654.
25. Fei L, Xia Y, Parker AS, Verma IM: IKK biology. Immunol Rev 2012; 246:239-253.
26. Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K: The kinase TAK1 can activate the NIK-Iκ B as well as the MAP kinase cascade in the IL-1 signaling pathway. Nature 1999; 398:252-256.
27. Wang C, Deng L, Hong M, Akkaraju GR, In-oue J, Chen ZJ: TAK1 is a ubiquitin-depen-dent kinase of MKK and IKK. Nature 2001; 412:346-351.
28. Meylan E, Burns K, Hofmann K, Blancheteau V, Martinon F, Kelliher M, Tschopp J: RIP1 is an essential mediator of Toll-like receptor 3-induced NF-κB activation. Nat Immunol 2004; 5:503-507.
29. Yang J, Lin Y, Guo Z, Cheng J, Huang J, Deng L, Liao W, Chen Z, Liu Z, Su B: The essential role of MEEKK3 in TNF-induced NF-κB activation. Nat Immunol 2001; 2:620-624.
30. Mattila PS, Ullman KS, Fiering S, Emmel EA, McCutcheon M, Crabtree GR, Herzen-berg LA: The actions of cyclosporine A and FK506 suggest a novel step in the activation of T lymphocytes. EMBO J 1990; 9:4425-4433.